Immunocore Holdings plc - ADR (IMCR) Company Profile & Statistics

Immunocore Holdings plc - ADR
IMCR
(Nasdaq - US)
N/A
60.18
+0.72 (+1.21%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
60.02
High
60.50
Low
59.57

About Immunocore Holdings plc - ADR

CEO

Bahija Jallal

Headquarters

92 park drive, milton park, abingdon

oxfordshire, x0 ox14 4ry, united kingdom

Auditor

KPMG LLP

Employees

497

Share Holders

Website

www.immunocore.com

Industry

biotechnology

Sector

health technology

Company Overview

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Immunocore Holdings plc - ADR Statistics

Valuation Measures

Market Capitalization ²	3B
Enterprise Value	2.60B
Enterprise Value/EBITDA (ttm)	-46.86
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	8.12
Price to Sales (ttm)	12.06
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	99.53%
Operating Margin (ttm)	-22.48%
Profit Margin (ttm)	-22.85%
Return on Equity (ttm)	-15.78%
Return on Invested Capital (ttm)	-13.24%
Return on Assets (ttm)	-9.91%

Income Statement

Revenue (ttm)	249.43M
Revenue Per Share (ttm)	5.01
Gross Profit (ttm)	248.39M
EBITDA (ttm)³	-55.56M
Net Income Avi to Common (ttm)	-55.29M
Diluted EPS (ttm)	-1.16

Share Statistics

Beta (5Y Monthly)	0.92
52-Week Change	0.58%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	49.82M
Dividend Yield	0.00%
Float ⁴	45.29M
% Held by Insiders	9.10%
% Held by Institutions	84.50%

Balance Sheet

Total Cash (mrq)	442.63M
Total Cash Per Share (mrq)	8.88
Total Debt (mrq)	48.01M
Total Debt/Equity (mrq)	13.02%
Current Ratio (mrq)	3.80%
Quick Ratio (mrq)	3.77%
Book Value Per Share (mrq)	7.42

Cash Flow

Operating Cash Flow Per Share (ytd)	0.06
Free Cash Flow (ytd)	-2.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Immunocore Holdings plc - ADR

Trade With A Regulated Broker